Skip to content

Past-year hallucinogen use in relation to psychological distress, depression, and suicidality among US adults.

Kevin H. Yang, Benjamin H Han, Joseph J Palamar

Addictive behaviors September 1, 2022 DOI: 10.1016/j.addbeh.2022.107343 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Observational cohort Peer reviewed
Sample size 241,675
Population US noninstitutionalized adults from the 2015-2020 National Survey on Drug Use and Health
Topics Depression LSD MDMA
Keywords Hallucinogens Psychedelics Suicidality Psychological distress Suicidal thoughts Mental well-being Mental health Explored Linked Reduced Decreased Distinct impacts Risks
Citations 30
Key findings LSD use was associated with increased likelihood of major depressive episode and suicidal thinking, while ecstasy use was associated with decreased likelihood of serious psychological distress, major depressive episode, and suicidal thinking.

Abstract

There is renewed interest in the clinical application of hallucinogenic substances to treat a range of psychiatric conditions. However, there is mixed evidence regarding how use of such substances outside of medical settings relates to psychological distress, depression, and suicidality. We examined data from a US representative sample of noninstitutionalized adults from the 2015-2020 National Survey on Drug Use and Health (N = 241,675). We evaluated whether past-year use of specific hallucinogens (i.e., LSD, DMT/AMT/Foxy, salvia divinorum, ecstasy [MDMA/Molly], ketamine) is associated with reporting past-year serious psychological distress (SPD), major depressive episode (MDE), and suicidality. Generalized linear models using Poisson and log link were used to estimate adjusted prevalence ratios (aPRs), controlling for sociodemographic characteristics and past-year use of various other illegal drugs. LSD use was associated with an increased likelihood of MDE (aPR = 1.23, 95% CI: 1.10-1.37) and suicidal thinking (aPR = 1.21, 95% CI: 1.09-1.34). Similar associations were observed between salvia divinorum use and suicidal thinking (aPR = 1.41, 95% CI: 1.00-1.97) and between DMT/AMT/Foxy use and suicidal planning (aPR = 1.81 95% CI: 1.17-2.81). On the other hand, ecstasy use was associated with a decreased likelihood of SPD (aPR = 0.83, 95% CI: 0.77-0.89), MDE (aPR = 0.91, 95% CI: 0.83-1.00), and suicidal thinking (aPR = 0.86, 95% CI: 0.75-0.99). Findings suggest there are differences among specific hallucinogens with respect to depression and suicidality. More research is warranted to understand consequences of and risk factors for hallucinogen use outside of medical settings among adults experiencing depression or suicidality.

In the evidence

This study is part of the evidence base for a synthesis in the library. Here is how each one recorded it.

  • Past-year ecstasy use was associated with a decreased likelihood of serious psychological distress, major depressive episode, and suicidal thinking, while LSD use was associated with increased likelihood of these outcomes.

    Synthesized

Comparable studies

Other observational and cohort studies on MDMA for depression, most cited first.

Study Year Design Participants
Symptoms of anxiety and depression in childhood and use of MDMA: prospective, population based study Children and adolescents from the Dutch province of Zuid-Holland 2006 Prospective longitudinal population-based study n = 1,580
Ecstasy (MDMA) and its Relationship with Self- Report Depression, Anxiety and Schizotypy Participants divided into three groups: no ecstasy use, light ecstasy users (fewer than... 2010 Observational cohort
The relationship between 3,4-methylenedioxymethamphetamine (MDMA) use in young adulthood and anxiety or depressive disorders in the mid-30s: Findings from the Victorian Adolescent Health Cohort Study. Year 9 students (aged 14-15) from 44 Victorian schools in Australia, followed to age 35 2025 Longitudinal population-based cohort study n = 1,943
Recreational ecstasy use and depression. Heavy ecstasy users and ecstasy-naive college students 2006 Observational cohort
Relationship between ecstasy use and depression: a study controlling for poly-drug use. Current MDMA users, ex-MDMA users, poly-drug controls who never used MDMA, and... 2004 Observational cohort n = 110

Explore topics

By condition and practice